[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Page 21858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08214]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP) GH20-001, Develop, Implement, and Evaluate 
Evidence-Based, Innovative Approaches To Prevent, Find, and Cure 
Tuberculosis in High-Burden Settings; GH20-002, Malaria Operations 
Research To Improve Malaria Control and Reduce Morbidity and Mortality 
in Western Kenya; GH20-003, Conducting Public Health Research in 
Colombia; GH20-004, Conducting Public Health Research in Georgia; and 
GH20-005, Conducting Public Health Research in South America; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--GH20-001, Develop, Implement, and Evaluate Evidence-based, 
Innovative Approaches to Prevent, Find, and Cure Tuberculosis in High-
Burden Settings; GH20-002, Malaria Operations Research to Improve 
Malaria Control and Reduce Morbidity and Mortality in Western Kenya; 
GH20-003, Conducting Public Health Research in Colombia; GH20-004, 
Conducting Public Health Research in Georgia; and GH20-005, Conducting 
Public Health Research in South America; April 14-16, 2020, 9:00 a.m.- 
2:00 p.m., EDT, in the amended FRN.
    The teleconference, which was published in the Federal Register on 
April 1, 2020, Vol. 85, No. 63, page 18243, is being amended to change 
the meeting dates and times to: April 14-15, 2020, from 9:00 a.m.-2:00 
p.m., EDT. The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Ph.D., Scientific Review 
Officer, Center for Global Health, CDC, 1600 Clifton Road NE, Atlanta, 
Georgia 30329-4027, Telephone (404) 639-4796; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-08214 Filed 4-17-20; 8:45 am]
BILLING CODE 4163-18-P